New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export ALC’s income statement to Excel — free account
Alcon
ALCHealthcare Medical Instruments & Supplies
Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024.
- Revenue
- +4.71%
- EPS
- +12.5%
- Free cash flow
- +13.3%
- Total debt
- +0.72%
Quarter to September 2026, against a year earlier
74.31
0.19
−0.26%
After hours trading: 74.32, up 0.01%, last trade 4:08pm Eastern.
Follow ALC
Alert me
Revenue to profit Q3 FY2026, quarter to Sep 30, 2026
Of every $100 of revenue, $9.50 was left as profit. What is an income statement?
| Revenue | 2.7 | 100.0% |
|---|---|---|
| Cost of revenue | −1.1 | −40.7% |
| Gross profit | 1.6 | 59.3% |
| Research & development | −0.3 | −9.5% |
| Selling, general & admin | −0.9 | −33.9% |
| Other operating costs | −0.1 | −1.9% |
| Operating income | 0.4 | 13.9% |
| Other income, net | −0.1 | −1.9% |
| Income tax | −0.1 | −2.5% |
| Net income | 0.3 | 9.5% |
Net margin (right axis)
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Revenue | $2.7B | $2.7B | $2.8B | $2.7B |
| Operating income | $313M | $292M | $11M | $381M |
| Net income | $217M | $189M | $0 | $260M |
| Net margin (right axis) | 8.0% | 7.0% | 0.0% | 9.5% |
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Revenue |
2,737.00 | 2,823.00 | 2,706.00 | 2,718.00 |
+8 more quarters Free account |
Revenue Growth |
4.71% | 8.74% | 9.42% | 8.63% | |
Cost of Revenue |
1,115.00 | 1,148.00 | 1,181.00 | 1,202.00 | |
Gross Profit |
1,622.00 | 1,675.00 | 1,525.00 | 1,516.00 | |
R&D Expenses |
261.00 | 663.00 | 245.00 | 273.00 | |
SG&A Expenses |
929.00 | 964.00 | 882.00 | 901.00 | |
Operating Income |
381.00 | 11.00 | 292.00 | 313.00 | |
Non-operating Interest Expenses |
52.00 | 53.00 | 52.00 | 53.00 | |
Non-operating Income/Expense |
(53.00) | (57.00) | (52.00) | (49.00) | |
| 328.00 | (46.00) | 240.00 | 264.00 | ||
Income Tax Provision |
68.00 | (46.00) | 51.00 | 47.00 | |
Income after Tax |
260.00 | — | 189.00 | 217.00 | |
Net Income Common |
260.00 | 0.00 | 189.00 | 217.00 | |
EPS (Basic) |
0.54 | 0.00 | 0.39 | 0.44 | |
EPS (Diluted) |
0.54 | 0.00 | 0.39 | 0.44 | |
Shares (Basic, Weighted) |
481.00 | 486.70 | 487.20 | 493.20 | |
Shares (Diluted, Weighted) |
483.30 | 488.70 | 490.20 | 496.20 | |
Gross Margin |
59.26% | 59.33% | 56.36% | 55.78% | |
EBIT Margin |
13.92% | 0.39% | 10.79% | 11.52% | |
EBT margin |
11.98% | (1.63%) | 8.87% | 9.71% | |
Net Profit Margin |
9.50% | 0.00% | 6.98% | 7.98% | |
EBITDA |
680.00 | 804.00 | 624.00 | 645.00 | |
EBIT |
381.00 | 11.00 | 292.00 | 313.00 | |
Income from Continuous Operations |
260.00 | — | 189.00 | 217.00 | |
Consolidated Net Income/Loss |
260.00 | 0.00 | 189.00 | 217.00 | |
EPS (Basic, from Continuous Ops) |
0.54 | — | 0.39 | 0.44 | |
EPS (Diluted, from Cont. Ops) |
0.54 | — | 0.39 | 0.44 | |
EPS (Basic, Consolidated) |
0.54 | — | 0.39 | 0.44 | |
EPS (Diluted, Consolidated) |
0.54 | — | 0.39 | 0.44 | |
Shares (Diluted, Average) |
483.30 | 488.70 | 490.20 | 492.30 | |
EBITDA Margin |
24.84% | 28.48% | 23.06% | 23.73% | |
Operating Cash Flow Margin |
27.80% | 18.07% | 15.45% | 24.21% |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 19, 2026